168 related articles for article (PubMed ID: 37439014)
1. Identification of TUBB4A as a Prognostic Biomarker of Melanoma by Transcriptomic Data and
Zhang J; Zhang Y; Liu J; Luo J; Yun Y; Cao Y
Technol Cancer Res Treat; 2023; 22():15330338231184842. PubMed ID: 37439014
[No Abstract] [Full Text] [Related]
2. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
Chen G; Yan J
Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
[TBL] [Abstract][Full Text] [Related]
3. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract][Full Text] [Related]
4. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis.
Ci C; Tang B; Lyu D; Liu W; Qiang D; Ji X; Qiu X; Chen L; Ding W
Int J Mol Med; 2019 Jan; 43(1):404-412. PubMed ID: 30431060
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma.
Yang S; Liu T; Nan H; Wang Y; Chen H; Zhang X; Zhang Y; Shen B; Qian P; Xu S; Sui J; Liang G
J Cell Physiol; 2020 Feb; 235(2):1025-1035. PubMed ID: 31240705
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
Wei CY; Zhu MX; Lu NH; Peng R; Yang X; Zhang PF; Wang L; Gu JY
Oncogene; 2019 Mar; 38(11):1876-1891. PubMed ID: 30385854
[TBL] [Abstract][Full Text] [Related]
9. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
10. CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration.
Li T; Wang L; Yu N; Zeng A; Huang J; Long X
Front Oncol; 2022; 12():1055308. PubMed ID: 36713580
[TBL] [Abstract][Full Text] [Related]
11. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma.
Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y
BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045
[TBL] [Abstract][Full Text] [Related]
12. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
13. Coexpressed Genes That Promote the Infiltration of M2 Macrophages in Melanoma Can Evaluate the Prognosis and Immunotherapy Outcome.
Yan K; Wang Y; Lu Y; Yan Z
J Immunol Res; 2021; 2021():6664791. PubMed ID: 33748290
[TBL] [Abstract][Full Text] [Related]
14. Qa-1b functions as an oncogenic factor in mouse melanoma cells.
Guo X; Fang Y; Guo C; Jia Q; Chi Z; Li J; Qin R; Tian J; Fan R
J Dermatol Sci; 2022 Mar; 105(3):159-169. PubMed ID: 35168832
[TBL] [Abstract][Full Text] [Related]
15. TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling.
Gao S; Wang S; Zhao Z; Zhang C; Liu Z; Ye P; Xu Z; Yi B; Jiao K; Naik GA; Wei S; Rais-Bahrami S; Bae S; Yang WH; Sonpavde G; Liu R; Wang L
Nat Commun; 2022 May; 13(1):2792. PubMed ID: 35589707
[TBL] [Abstract][Full Text] [Related]
16. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
Sun X; Zhang J; Hu J; Han Q; Ge Z
BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide inhibits melanoma in vitro and in vivo.
Scatozza F; Moschella F; D'Arcangelo D; Rossi S; Tabolacci C; Giampietri C; Proietti E; Facchiano F; Facchiano A
J Exp Clin Cancer Res; 2020 Oct; 39(1):211. PubMed ID: 33028392
[TBL] [Abstract][Full Text] [Related]
18. Identification of IL10RA by Weighted Correlation Network Analysis and
Cheng S; Li Z; Zhang W; Sun Z; Fan Z; Luo J; Liu H
Front Cell Dev Biol; 2020; 8():630790. PubMed ID: 33490091
[TBL] [Abstract][Full Text] [Related]
19. Prognostic score model-based signature genes for predicting the prognosis of metastatic skin cutaneous melanoma.
Wang J
Math Biosci Eng; 2021 Jun; 18(5):5125-5145. PubMed ID: 34517481
[TBL] [Abstract][Full Text] [Related]
20. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L
Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]